Longitudinal Improvements in Viral Suppression for Persons With New HIV Diagnosis Receiving Care in the Ryan White Program: A 10-Year Experience in New Haven, CT (2009–2018)

Abstract Background The Ryan White (RW) program funds medical and other support services for low-income persons with HIV, significantly improving progress along the HIV care continuum. Although the program has shown overall improvements in achievement of viral suppression, the relative contributions of changes in clinical practice and RW service components to the optimization of the HIV care continuum, particularly for those with new HIV diagnoses, remain unknown. Methods The target population was patients with recent HIV diagnoses who received care at RW-funded clinics in the greater New Haven area between 2009 and 2018. Client data were extracted from the RW-funded database, CAREWare, and the electronic medical record. Primary outcomes included time between HIV diagnosis and first HIV primary care (PC) visit, antiretroviral therapy (ART) initiation, and viral suppression (VS). Results There were 386 eligible patients. Between 2009 and 2018, the median number of days from HIV diagnosis to first PC visit decreased from 58.5 to 8.5 days, and ART initiation decreased from 155 to 9 days. In 2018, 86% of participants achieved viral suppression within 1 year, compared with 2.5% in 2009. Patients who initiated single-tablet ART and integrase inhibitor–containing regimens were more likely to reach viral suppression within 1 year (P < .001). Receipt of medical case management services was also associated with achieving viral suppression (P < .001). Conclusions Longitudinal improvements over 10 years in ART initiation and viral suppression were observed due to clinical advances and their effective implementation through the RW comprehensive care model. Further study of the essential components promoting these outcomes is needed.

[1]  S. Buchbinder,et al.  Decreased Time from HIV Diagnosis to Care, ART Initiation, and Virologic Suppression during the Citywide RAPID Initiative in San Francisco. , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[2]  M. Friend,et al.  Diagnoses of HIV infection in the United States and dependent areas (updated), 2018 , 2020 .

[3]  L. Myers,et al.  A Care Continuum of Immediate ART for Newly Diagnosed Patients and Patients Presenting Later to Care at a Federally Qualified Health Center in New Orleans , 2019, Open forum infectious diseases.

[4]  D. Havlir,et al.  RAPID antiretroviral therapy: high virologic suppression rates with immediate antiretroviral therapy initiation in a vulnerable urban clinic population. , 2019, AIDS.

[5]  O. Ogbuagu,et al.  Integrase inhibitor-based regimens result in more rapid virologic suppression rates among treatment-naïve human immunodeficiency virus–infected patients compared to non-nucleoside and protease inhibitor–based regimens in a real-world clinical setting , 2018, Medicine.

[6]  E. Shacham,et al.  The Impact of the Ryan White HIV/AIDS Medical Case Management Program on HIV Clinical Outcomes: A Longitudinal Study , 2018, AIDS and behavior.

[7]  C. del Rio,et al.  Implementation of a Rapid Entry Program Decreases Time to Viral Suppression Among Vulnerable Persons Living With HIV in the Southern United States , 2018, Open forum infectious diseases.

[8]  N. Ford,et al.  Benefits and risks of rapid initiation of antiretroviral therapy , 2017, AIDS.

[9]  J. Sterne,et al.  Survival of HIV-positive patients starting antiretroviral therapy between 1996 and 2013: a collaborative analysis of cohort studies , 2017, The lancet. HIV.

[10]  H. Hatano,et al.  The Effect of Same-Day Observed Initiation of Antiretroviral Therapy on HIV Viral Load and Treatment Outcomes in a US Public Health Setting , 2017, Journal of acquired immune deficiency syndromes.

[11]  C. del Rio,et al.  Continuous Retention and Viral Suppression Provide Further Insights Into the HIV Care Continuum Compared to the Cross-sectional HIV Care Cascade. , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[12]  J. Skarbinski,et al.  Ryan White HIV/AIDS Program Assistance and HIV Treatment Outcomes. , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[13]  J. Skarbinski,et al.  Service Delivery and Patient Outcomes in Ryan White HIV/AIDS Program-Funded and -Nonfunded Health Care Facilities in the United States. , 2015, JAMA internal medicine.

[14]  H. Lane,et al.  Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection. , 2015, The New England journal of medicine.

[15]  R. Salamon,et al.  A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa. , 2015, The New England journal of medicine.

[16]  A. Samri,et al.  Combined ART started during acute HIV infection protects central memory CD4+ T cells and can induce remission. , 2015, The Journal of antimicrobial chemotherapy.

[17]  N. Abrescia,et al.  Efficacy and Tolerability of Integrase Inhibitors in Antiretroviral-Naive Patients. , 2015, AIDS reviews.

[18]  E. Phillips,et al.  The evolution of three decades of antiretroviral therapy: challenges, triumphs and the promise of the future. , 2015, British journal of clinical pharmacology.

[19]  S. Braunstein,et al.  Improvements in HIV care engagement and viral load suppression following enrollment in a comprehensive HIV care coordination program. , 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[20]  L. Cheever,et al.  High rates of retention and viral suppression in the US HIV safety net system: HIV care continuum in the Ryan White HIV/AIDS Program, 2011. , 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[21]  J. Skarbinski,et al.  Behavioral and clinical characteristics of persons receiving medical care for HIV infection - Medical Monitoring Project, United States, 2009. , 2014, MMWR supplements.

[22]  P. Harrigan,et al.  Expansion of HAART Coverage Is Associated with Sustained Decreases in HIV/AIDS Morbidity, Mortality and HIV Transmission: The “HIV Treatment as Prevention” Experience in a Canadian Setting , 2014, PloS one.

[23]  R Core Team,et al.  R: A language and environment for statistical computing. , 2014 .

[24]  H. Hatano,et al.  Antiretroviral therapy initiated within 6 months of HIV infection is associated with lower T-cell activation and smaller HIV reservoir size. , 2013, The Journal of infectious diseases.

[25]  Steven C. Johnson,et al.  Initial Linkage and Subsequent Retention in HIV Care for a Newly Diagnosed HIV-Infected Cohort in Denver, Colorado , 2013, Journal of the International Association of Providers of AIDS Care.

[26]  E. Vittinghoff,et al.  Decreases in Community Viral Load Are Accompanied by Reductions in New HIV Infections in San Francisco , 2010, PloS one.

[27]  J. Willig,et al.  The therapeutic implications of timely linkage and early retention in HIV care. , 2009, AIDS patient care and STDs.

[28]  A. Westfall,et al.  Missed visits and mortality among patients establishing initial outpatient HIV treatment. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[29]  Christopher Dye,et al.  Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model , 2009, The Lancet.

[30]  S. Hammer,et al.  Antiretroviral therapy for HIV infection in 1996. Recommendations of an international panel. International AIDS Society-USA. , 1996, JAMA.